+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cancer Cachexia Market Size, Share & Trends Analysis Report by Treatment (Appetite Stimulants, Corticosteroids), Type (Lung Cancer, Colorectal Cancer), Distribution Channel and Region with Growth Forecasts, 2025-2033

  • PDF Icon

    Report

  • 150 Pages
  • November 2025
  • Region: Global
  • Grand View Research
  • ID: 6214548
REQUEST CUSTOMIZATION
Description Jump to:
The global cancer cachexia market size was estimated at USD 2.54 billion in 2024 and is projected to reach USD 3.90 billion by 2033, growing at a CAGR of 4.86% from 2025 to 2033. The rising cancer incidence and more patients with cachexia, and growing recognition of cachexia’s clinical & economic impact, drive the market.

According to a report published by NIH in November 2023, Cancer-related cachexia affects up to 74% of cancer patients. It is directly responsible for 20-30% of cancer deaths, making it the main cause of death in 22-30% of cases. The increasing focus on supportive care in oncology is also driving market growth. However, increasing healthcare spending and improving access to cancer care in emerging markets are helping expand the potential customer base. As more patients receive cancer diagnoses and treatment worldwide, the need for cachexia management grows, which is expected to drive the growth of the cancer cachexia industry.

Global Cancer Cachexia Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global cancer cachexia market report based on treatment, type, distribution channel, and region:

Treatment Outlook (Revenue, USD Million, 2021-2033)

  • Appetite Stimulants
  • Cannabinoid Receptor Agonists
  • Corticosteroids
  • Anabolic/Androgenic Agents
  • Others

Type Outlook (Revenue, USD Million, 2021-2033)

  • Pancreatic Cancer
  • Gastric (Stomach) Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Others

Distribution Channel Outlook (Revenue, USD Million, 2021-2033)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Treatment
1.2.2. Type
1.2.3. Distribution channel
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Treatment outlook
2.2.2. Type outlook
2.2.3. Distribution channel outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Cancer Cachexia Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Cancer Cachexia Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.4. Cancer Cachexia Market: Pipeline Analysis
Chapter 4. Cancer Cachexia Market: Treatment Estimates & Trend Analysis
4.1. Treatment Segment Dashboard
4.2. Cancer Cachexia Market: Treatment Movement Analysis
4.3. Global Cancer Cachexia Market Size & Trend Analysis, by Treatment, 2021 to 2033 (USD Million)
4.3.1. Appetite stimulants
4.3.1.1. Market estimates and forecasts, 2021-2033 (USD Million)
4.3.2. Cannabinoid receptor agonists
4.3.2.1. Market estimates and forecasts, 2021-2033 (USD Million)
4.3.3. Corticosteroids
4.3.3.1. Market estimates and forecasts, 2021-2033 (USD Million)
4.3.4. Anabolic/androgenic agents
4.3.4.1. Market estimates and forecasts, 2021-2033 (USD Million)
4.3.5. Others
4.3.5.1. Market estimates and forecasts, 2021-2033 (USD Million)
Chapter 5. Cancer Cachexia Market: Type Estimates & Trend Analysis
5.1. Type Segment Dashboard
5.2. Cancer Cachexia Market: Type Movement Analysis
5.3. Global Cancer Cachexia Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
5.3.1. Pancreatic cancer
5.3.1.1. Market estimates and forecasts, 2021-2033 (USD Million)
5.3.2. Gastric (stomach) cancer
5.3.2.1. Market estimates and forecasts, 2021-2033 (USD Million)
5.3.3. Lung cancer
5.3.3.1. Market estimates and forecasts, 2021-2033 (USD Million)
5.3.4. Colorectal cancer
5.3.4.1. Market estimates and forecasts, 2021-2033 (USD Million)
5.3.5. Others
5.3.5.1. Market estimates and forecasts, 2021-2033 (USD Million)
Chapter 6. Cancer Cachexia Market: Distribution Channel Estimates & Trend Analysis
6.1. Distribution Channel Segment Dashboard
6.2. Cancer Cachexia Market: Distribution Channel Movement Analysis
6.3. Global Cancer Cachexia Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
6.3.1. Hospital Pharmacies
6.3.1.1. Market estimates and forecasts, 2021-2033 (USD Million)
6.3.2. Retail Pharmacies
6.3.2.1. Market estimates and forecasts, 2021-2033 (USD Million)
6.3.3. Online Pharmacies
6.3.3.1. Market estimates and forecasts, 2021-2033 (USD Million)
Chapter 7. Cancer Cachexia Market: Regional Estimates & Trend Analysis
7.1. Regional Market Dashboard
7.2. Regional Market Share Analysis, 2024 & 2033
7.3. Cancer Cachexia Market by Region: Key Takeaways
7.4. North America
7.4.1. U.S.
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework/ reimbursement structure
7.4.1.3. Competitive scenario
7.4.1.4. U.S. market estimates and forecasts, 2021-2033 (USD Million)
7.4.2. Canada
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. Canada market estimates and forecasts, 2021-2033 (USD Million)
7.4.3. Mexico
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. Mexico market estimates and forecasts, 2021-2033 (USD Million)
7.5. Europe
7.5.1. UK
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. UK market estimates and forecasts, 2021-2033 (USD Million)
7.5.2. Germany
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. Germany market estimates and forecasts, 2021-2033 (USD Million)
7.5.3. France
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. France market estimates and forecasts, 2021-2033 (USD Million)
7.5.4. Italy
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. Italy market estimates and forecasts, 2021-2033 (USD Million)
7.5.5. Spain
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. Spain market estimates and forecasts, 2021-2033 (USD Million)
7.5.6. Sweden
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Sweden market estimates and forecasts, 2021-2033 (USD Million)
7.5.7. Denmark
7.5.7.1. Key country dynamics
7.5.7.2. Regulatory framework/ reimbursement structure
7.5.7.3. Competitive scenario
7.5.7.4. Denmark market estimates and forecasts, 2021-2033 (USD Million)
7.5.8. Norway
7.5.8.1. Key country dynamics
7.5.8.2. Regulatory framework/ reimbursement structure
7.5.8.3. Competitive scenario
7.5.8.4. Norway market estimates and forecasts, 2021-2033 (USD Million)
7.6. Asia-Pacific
7.6.1. China
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. China market estimates and forecasts, 2021-2033 (USD Million)
7.6.2. India
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. India market estimates and forecasts, 2021-2033 (USD Million)
7.6.3. Japan
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/ reimbursement structure
7.6.3.3. Competitive scenario
7.6.3.4. Japan market estimates and forecasts, 2021-2033 (USD Million)
7.6.4. Australia
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework/ reimbursement structure
7.6.4.3. Competitive scenario
7.6.4.4. Australia market estimates and forecasts, 2021-2033 (USD Million)
7.6.5. South Korea
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework/ reimbursement structure
7.6.5.3. Competitive scenario
7.6.5.4. South Korea market estimates and forecasts, 2021-2033 (USD Million)
7.6.6. Thailand
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework/ reimbursement structure
7.6.6.3. Competitive scenario
7.6.6.4. Thailand market estimates and forecasts, 2021-2033 (USD Million)
7.7. Latin America
7.7.1. Brazil
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. Brazil market estimates and forecasts, 2021-2033 (USD Million)
7.7.2. Argentina
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Argentina market estimates and forecasts, 2021-2033 (USD Million)
7.8. MEA
7.8.1. South Africa
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework/ reimbursement structure
7.8.1.3. Competitive scenario
7.8.1.4. South Africa market estimates and forecasts, 2021-2033 (USD Million)
7.8.2. Saudi Arabia
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework/ reimbursement structure
7.8.2.3. Competitive scenario
7.8.2.4. Saudi Arabia market estimates and forecasts, 2021-2033 (USD Million)
7.8.3. UAE
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework/ reimbursement structure
7.8.3.3. Competitive scenario
7.8.3.4. UAE market estimates and forecasts, 2021-2033 (USD Million)
7.8.4. Kuwait
7.8.4.1. Key country dynamics
7.8.4.2. Regulatory framework/ reimbursement structure
7.8.4.3. Competitive scenario
7.8.4.4. Kuwait market estimates and forecasts, 2021-2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. Key company heat map analysis, 2024
8.4. Company Profiles
8.4.1. AbbVie Inc.
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Endo, Inc.
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Teva Pharmaceutical Industries Ltd.
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Pfizer Inc.
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Abbott.
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Nestlé Health Science
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Baxter.
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Fresenius Kabi AG
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Sandoz Group AG
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. Bristol-Myers Squibb Company
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
List of Tables
Table 1 Global cancer cachexia market, by region, 2021-2033 (USD Million)
Table 2 Global cancer cachexia market, by treatment, 2021-2033 (USD Million)
Table 3 Global cancer cachexia market, by type, 2021-2033 (USD Million)
Table 4 Global cancer cachexia market, by distribution channel, 2021-2033 (USD Million)
Table 5 North America cancer cachexia market, by country, 2021-2033 (USD Million)
Table 6 North America cancer cachexia market, by treatment, 2021-2033 (USD Million)
Table 7 North America cancer cachexia market, by type, 2021-2033 (USD Million)
Table 8 North America cancer cachexia market, by distribution channel, 2021-2033 (USD Million)
Table 9 U.S. cancer cachexia market, by treatment, 2021-2033 (USD Million)
Table 10 U.S. cancer cachexia market, by type, 2021-2033 (USD Million)
Table 11 U.S. cancer cachexia market, by distribution channel, 2021-2033 (USD Million)
Table 12 Canada cancer cachexia market, by treatment, 2021-2033 (USD Million)
Table 13 Canada cancer cachexia market, by type, 2021-2033 (USD Million)
Table 14 Canada cancer cachexia market, by distribution channel, 2021-2033 (USD Million)
Table 15 Mexico cancer cachexia market, by treatment, 2021-2033 (USD Million)
Table 16 Mexico cancer cachexia market, by type, 2021-2033 (USD Million)
Table 17 Mexico cancer cachexia market, by distribution channel, 2021-2033 (USD Million)
Table 18 Europe cancer cachexia market, by country, 2021-2033 (USD Million)
Table 19 Europe cancer cachexia market, by treatment, 2021-2033 (USD Million)
Table 20 Europe cancer cachexia market, by type, 2021-2033 (USD Million)
Table 21 Europe cancer cachexia market, by distribution channel, 2021-2033 (USD Million)
Table 22 Germany cancer cachexia market, by treatment, 2021-2033 (USD Million)
Table 23 Germany cancer cachexia market, by type, 2021-2033 (USD Million)
Table 24 Germany cancer cachexia market, by distribution channel, 2021-2033 (USD Million)
Table 25 UK cancer cachexia market, by treatment, 2021-2033 (USD Million)
Table 26 UK cancer cachexia market, by type, 2021-2033 (USD Million)
Table 27 UK cancer cachexia market, by distribution channel, 2021-2033 (USD Million)
Table 28 France cancer cachexia market, by treatment, 2021-2033 (USD Million)
Table 29 France cancer cachexia market, by type, 2021-2033 (USD Million)
Table 30 France cancer cachexia market, by distribution channel, 2021-2033 (USD Million)
Table 31 Italy cancer cachexia market, by treatment, 2021-2033 (USD Million)
Table 32 Italy cancer cachexia market, by type, 2021-2033 (USD Million)
Table 33 Italy cancer cachexia market, by distribution channel, 2021-2033 (USD Million)
Table 34 Spain cancer cachexia market, by treatment, 2021-2033 (USD Million)
Table 35 Spain cancer cachexia market, by type, 2021-2033 (USD Million)
Table 36 Spain cancer cachexia market, by distribution channel, 2021-2033 (USD Million)
Table 37 Denmark cancer cachexia market, by treatment, 2021-2033 (USD Million)
Table 38 Denmark cancer cachexia market, by type, 2021-2033 (USD Million)
Table 39 Denmark cancer cachexia market, by distribution channel, 2021-2033 (USD Million)
Table 40 Sweden cancer cachexia market, by treatment, 2021-2033 (USD Million)
Table 41 Sweden cancer cachexia market, by type, 2021-2033 (USD Million)
Table 42 Sweden cancer cachexia market, by distribution channel, 2021-2033 (USD Million)
Table 43 Norway cancer cachexia market, by treatment, 2021-2033 (USD Million)
Table 44 Norway cancer cachexia market, by type, 2021-2033 (USD Million)
Table 45 Norway cancer cachexia market, by distribution channel, 2021-2033 (USD Million)
Table 46 Asia-Pacific cancer cachexia market, by country, 2021-2033 (USD Million)
Table 47 Asia-Pacific cancer cachexia market, by treatment, 2021-2033 (USD Million)
Table 48 Asia-Pacific cancer cachexia market, by type, 2021-2033 (USD Million)
Table 49 Asia-Pacific cancer cachexia market, by distribution channel, 2021-2033 (USD Million)
Table 50 China cancer cachexia market, by treatment, 2021-2033 (USD Million)
Table 51 China cancer cachexia market, by type, 2021-2033 (USD Million)
Table 52 China cancer cachexia market, by distribution channel, 2021-2033 (USD Million)
Table 53 Japan cancer cachexia market, by treatment, 2021-2033 (USD Million)
Table 54 Japan cancer cachexia market, by type, 2021-2033 (USD Million)
Table 55 Japan cancer cachexia market, by distribution channel, 2021-2033 (USD Million)
Table 56 India cancer cachexia market, by treatment, 2021-2033 (USD Million)
Table 57 India cancer cachexia market, by type, 2021-2033 (USD Million)
Table 58 India cancer cachexia market, by distribution channel, 2021-2033 (USD Million)
Table 59 South Korea cancer cachexia market, by treatment, 2021-2033 (USD Million)
Table 60 South Korea cancer cachexia market, by type, 2021-2033 (USD Million)
Table 61 South Korea cancer cachexia market, by distribution channel, 2021-2033 (USD Million)
Table 62 Australia cancer cachexia market, by treatment, 2021-2033 (USD Million)
Table 63 Australia cancer cachexia market, by type, 2021-2033 (USD Million)
Table 64 Australia cancer cachexia market, by distribution channel, 2021-2033 (USD Million)
Table 65 Thailand cancer cachexia market, by treatment, 2021-2033 (USD Million)
Table 66 Thailand cancer cachexia market, by type, 2021-2033 (USD Million)
Table 67 Thailand cancer cachexia market, by distribution channel, 2021-2033 (USD Million)
Table 68 Latin America cancer cachexia market, by country, 2021-2033 (USD Million)
Table 69 Latin America cancer cachexia market, by treatment, 2021-2033 (USD Million)
Table 70 Latin America cancer cachexia market, by type, 2021-2033 (USD Million)
Table 71 Latin America cancer cachexia market, by distribution channel, 2021-2033 (USD Million)
Table 72 Brazil cancer cachexia market, by treatment, 2021-2033 (USD Million)
Table 73 Brazil cancer cachexia market, by type, 2021-2033 (USD Million)
Table 74 Brazil cancer cachexia market, by distribution channel, 2021-2033 (USD Million)
Table 75 Argentina cancer cachexia market, by treatment, 2021-2033 (USD Million)
Table 76 Argentina cancer cachexia market, by type, 2021-2033 (USD Million)
Table 77 Argentina cancer cachexia market, by distribution channel, 2021-2033 (USD Million)
Table 78 Middle East & Africa cancer cachexia market, by country, 2021-2033 (USD Million)
Table 79 Middle East & Africa cancer cachexia market, by treatment, 2021-2033 (USD Million)
Table 80 Middle East & Africa cancer cachexia market, by type, 2021-2033 (USD Million)
Table 81 Middle East & Africa cancer cachexia market, by distribution channel, 2021-2033 (USD Million)
Table 82 South Africa cancer cachexia market, by treatment, 2021-2033 (USD Million)
Table 83 South Africa cancer cachexia market, by type, 2021-2033 (USD Million)
Table 84 South Africa cancer cachexia market, by distribution channel, 2021-2033 (USD Million)
Table 85 Saudi Arabia cancer cachexia market, by treatment, 2021-2033 (USD Million)
Table 86 Saudi Arabia cancer cachexia market, by type, 2021-2033 (USD Million)
Table 87 Saudi Arabia midline carcinoma treatment market, by distribution channel, 2021-2033 (USD Million)
Table 88 UAE cancer cachexia market, by treatment, 2021-2033 (USD Million)
Table 89 UAE cancer cachexia market, by type, 2021-2033 (USD Million)
Table 90 UAE cancer cachexia market, by distribution channel, 2021-2033 (USD Million)
Table 91 Kuwait cancer cachexia market, by treatment, 2021-2033 (USD Million)
Table 92 Kuwait cancer cachexia market, by type, 2021-2033 (USD Million)
Table 93 Kuwait cancer cachexia market, by distribution channel, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 Market formulation & validation
Figure 7 Market snapshot
Figure 8 Cancer cachexia market segmentation
Figure 9 Market snapshot
Figure 10 Therapeutic approach and disease outlook (USD Million)
Figure 11 Competitive landscape
Figure 12 Cancer cachexia market dynamics
Figure 13 Cancer cachexia market: Porter’s five forces analysis
Figure 14 Cancer cachexia market: PESTLE analysis
Figure 15 Treatment market, 2021-2033 (USD Million)
Figure 16 Appetite stimulants market estimates and forecast, 2021-2033 (USD Million)
Figure 17 Cannabinoid receptor agonists market estimates and forecast, 2021-2033 (USD Million)
Figure 18 Corticosteroids market estimates and forecast, 2021-2033 (USD Million)
Figure 19 Anabolic/androgenic agents market estimates and forecast, 2021-2033 (USD Million)
Figure 20 Others market estimates and forecast, 2021-2033 (USD Million)
Figure 21 Type market, 2021-2033 (USD Million)
Figure 22 Pancreatic cancer market estimates and forecast, 2021-2033 (USD Million)
Figure 23 Gastric (stomach) cancer market estimates and forecast, 2021-2033 (USD Million)
Figure 24 Lung cancer market estimates and forecast, 2021-2033 (USD Million)
Figure 25 Colorectal cancer market estimates and forecast, 2021-2033 (USD Million)
Figure 26 Others market estimates and forecast, 2021-2033 (USD Million)
Figure 27 Distribution channel market, 2021-2033 (USD Million)
Figure 28 Hospital pharmacies estimates and forecast, 2021-2033 (USD Million)
Figure 29 Retail pharmacies market, 2021-2033 (USD Million)
Figure 30 Online pharmacies estimates and forecast, 2021-2033 (USD Million)
Figure 31 Cancer cachexia market revenue, by region
Figure 32 Regional marketplace: Key takeaways
Figure 33 North America cancer cachexia market, 2021-2033 (USD Million)
Figure 34 U.S. country dynamics
Figure 35 U.S. cancer cachexia market, 2021-2033 (USD Million)
Figure 36 Canada country dynamics
Figure 37 Canada cancer cachexia market, 2021-2033 (USD Million)
Figure 38 Mexico country dynamics
Figure 39 Mexico cancer cachexia market, 2021-2033 (USD Million)
Figure 40 Europe cancer cachexia market, 2021-2033 (USD Million)
Figure 41 UK country dynamics
Figure 42 UK cancer cachexia market, 2021-2033 (USD Million)
Figure 43 Germany country dynamics
Figure 44 Germany cancer cachexia market, 2021-2033 (USD Million)
Figure 45 France country dynamics
Figure 46 France cancer cachexia market, 2021-2033 (USD Million)
Figure 47 Italy country dynamics
Figure 48 Italy cancer cachexia market, 2021-2033 (USD Million)
Figure 49 Spain country dynamics
Figure 50 Spain cancer cachexia market, 2021-2033 (USD Million)
Figure 51 Norway country dynamics
Figure 52 Norway cancer cachexia market, 2021-2033 (USD Million)
Figure 53 Sweden country dynamics
Figure 54 Sweden cancer cachexia market, 2021-2033 (USD Million)
Figure 55 Denmark country dynamics
Figure 56 Denmark cancer cachexia market, 2021-2033 (USD Million)
Figure 57 Asia-Pacific cancer cachexia market, 2021-2033 (USD Million)
Figure 58 Japan country dynamics
Figure 59 Japan cancer cachexia market, 2021-2033 (USD Million)
Figure 60 China country dynamics
Figure 61 China cancer cachexia market, 2021-2033 (USD Million)
Figure 62 India country dynamics
Figure 63 India cancer cachexia market, 2021-2033 (USD Million)
Figure 64 Australia country dynamics
Figure 65 Australia cancer cachexia market, 2021-2033 (USD Million)
Figure 66 South Korea country dynamics
Figure 67 South Korea cancer cachexia market, 2021-2033 (USD Million)
Figure 68 Thailand country dynamics
Figure 69 Thailand cancer cachexia market, 2021-2033 (USD Million)
Figure 70 Latin America cancer cachexia market, 2021-2033 (USD Million)
Figure 71 Brazil country dynamics
Figure 72 Brazil cancer cachexia market, 2021-2033 (USD Million)
Figure 73 Argentina country dynamics
Figure 74 Argentina cancer cachexia market, 2021-2033 (USD Million)
Figure 75 MEA cancer cachexia market, 2021-2033 (USD Million)
Figure 76 South Africa country dynamics
Figure 77 South Africa cancer cachexia market, 2021-2033 (USD Million)
Figure 78 Saudi Arabia country dynamics
Figure 79 Saudi Arabia cancer cachexia market, 2021-2033 (USD Million)
Figure 80 UAE country dynamics
Figure 81 UAE cancer cachexia market, 2021-2033 (USD Million)
Figure 82 Kuwait country dynamics
Figure 83 Kuwait cancer cachexia market, 2021-2033 (USD Million)
Figure 84 Company categorization
Figure 85 Company market position analysis
Figure 86 Strategic framework

Companies Mentioned

The key companies profiled in this Cancer Cachexia market report include:
  • AbbVie Inc.
  • Endo, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Abbott.
  • Nestlé Health Science
  • Baxter.
  • Fresenius Kabi AG
  • Sandoz Group AG
  • Bristol-Myers Squibb Company

Table Information

Report AttributeDetails
No. of Pages150
PublishedNovember 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 2.54 Billion
Forecasted Market Value ( USD ) by 2033 $ 3.9 Billion
Compound Annual Growth Rate4.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Cancer Cachexia Market Report by Therapeutics, Mode of Action, Distribution Channel, and Region 2025-2033 - Product Image

Cancer Cachexia Market Report by Therapeutics, Mode of Action, Distribution Channel, and Region 2025-2033

  • Report
  • 134 Pages
  • Global
From
Cancer Cachexia (CC) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Cancer Cachexia (CC) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Cancer Anorexia-Cachexia Syndrome (CACS) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Cancer Anorexia-Cachexia Syndrome (CACS) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Cancer Cachexia - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Cancer Cachexia - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 115 Pages
  • Global
From
Cancer Cachexia Market - Forecasts from 2024 to 2029 - Product Image

Cancer Cachexia Market - Forecasts from 2024 to 2029

  • Report
  • 145 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.